AHRQ Stepping Up Cost-Effectiveness Research; Says Key Is Openness
Executive Summary
The Agency for Healthcare Research & Quality is ready to take on a new role in cost-effectiveness research, Director Carolyn Clancy, MD, said at an AHRQ National Advisory Council meeting Nov. 7
You may also be interested in...
PhRMA Adopts Outcomes Research Policy; Set For Cost-Effectiveness Debate
Government-supported health outcomes research must recognize the benefits of multiple treatment options, the Pharmaceutical Research & Manufacturers of America's principles on outcomes research say
PhRMA Adopts Outcomes Research Policy; Set For Cost-Effectiveness Debate
Government-supported health outcomes research must recognize the benefits of multiple treatment options, the Pharmaceutical Research & Manufacturers of America's principles on outcomes research say
AHRQ Comparative Trial Funding Awaits Supplemental Appropriation
The comparative trial/cost effectiveness provisions in the Medicare legislation will require a supplemental appropriation for the Agency for Healthcare Research & Quality